Global analysis of epigenetic heterogeneity identifies divergent drivers of esophageal squamous cell carcinoma

Wei Cao,Hayan Lee,Wei Wu,Aubhishek Zaman,Sean McCorkle,Ming Yan,Justin Chen,Qinghe Xing,Nasa Sinnott-Armstrong,Hongen Xu,M.Reza Sailani,Wenxue Tang,Yuanbo Cui,Jia Liu,Hongya Guan,Pengju Lv,Xiaoyan Sun,Lei Sun,Pengli Han,Yanan Lou,Jing Chang,Jinwu Wang,Yuchi Gao,Jiancheng Guo,Gundolf Schenk,Alan Hunter Shain,Fred G. Biddle,Eric Collisson,Michael Snyder,Trever G. Bivona

DOI: https://doi.org/10.1101/641357

2019-01-01

bioRxiv

Abstract:Epigenetic landscapes can shape physiologic and disease phenotypes. We used integrative, high resolution multi-omics methods to characterize the oncogenic drivers of esophageal squamous cell carcinoma (ESCC). We found 98% of CpGs are hypomethylated across the ESCC genome and two-thirds occur in long non-coding (lnc)RNA regions. DNA methylation and epigenetic heterogeneity both coincide with chromosomal topological alterations. Gene body methylation, polycomb repressive complex occupancy, and CTCF binding sites associate with cancer-specific gene regulation. Epigenetically-mediated activation of non-canonical WNT signaling and the lncRNA were validated as potential ESCC driver alterations. Gene-specific cancer driver roles of epigenetic alterations and heterogeneity are identified.